The 2nd phase of PARTNER study has received funding from the NIHR (National Institute for Health Research in the UK), A.P. Møller Foundation, Augustinus Foundation, ViiV and GILEAD and is sponsored by CHIP Rigshospitalet. Additionally funding for participation of the Swiss centres has been provided by the Swiss Office of Public Health. The study is coordinated cooperatively between CHIP (Centre for health and infectious disease research), UCL and Royal Free NHS. The ethics committees in all of the 14 countries have by December 2014 approved the 2nd phase of PARTNER.
The PARTNER Study presented data at CROI 2014 in Boston
HIV transmission risk through condomless sex if the HIV positive partner is on suppressive ART: PARTNER study A Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, V Estrada, J Van Lunzen, GM Corbelli, AM Geretti, D Asboe, P Viciano, F Gutiérrez, C Pradier, K Westling, R Weber, H Furrer, J Prins, J Gerstoft, A Phillips and J Lundgren for the PARTNER Study Group.
Q & A
Tina Bruun, Nurse MSA
Projector coordinator for PARTNER
Direct: + 45 35 45 57 93
Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases, Section 2100
DK-2100 Copenhagen Ø, Denmark
Prof. Andrew Phillips and Dr Alison Rodger
Research Department of Infection & Population Health
Royal Free Campus
Rowland Hill Street
London, NW3 2 PF